TENAX THERAPEUTICS, INC. Annual Interest Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Tenax Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
  • Tenax Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2024 was $6.31K, a 18.3% increase year-over-year.
  • Tenax Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2024 was $25.6K, a 17.4% increase year-over-year.
  • Tenax Therapeutics, Inc. annual Interest Expense for 2023 was $24K, a 439% increase from 2022.
  • Tenax Therapeutics, Inc. annual Interest Expense for 2022 was $4.44K, a 368% increase from 2021.
  • Tenax Therapeutics, Inc. annual Interest Expense for 2021 was $949.000, a 41.7% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $24K +$19.5K +439% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $4.44K +$3.49K +368% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $949 -$678 -41.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $1.63K +$1.63K Jan 1, 2020 Dec 31, 2020 10-K/A 2021-04-16
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-16
2016 $0 Jan 1, 2016 Dec 31, 2016 10-K 2017-03-16
2014 $49.1K -$2.16M -97.8% May 1, 2014 Apr 30, 2015 10-K 2017-03-16
2013 $2.21M +$2.21M +52095% May 1, 2013 Apr 30, 2014 10-K 2017-03-16
2012 $4.24K -$7.41M May 1, 2012 Apr 30, 2013 10-KT 2016-03-14
2011 $7.41M* +$7.58M May 1, 2011 Apr 30, 2012 10-K 2013-06-26
2010 -$172K May 1, 2010 Apr 30, 2011 10-K 2012-07-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.